enVVeno Medical Corporation
NVNO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.67M
Close$
$4.02
40.3% downside
Current Fair Value
40.3% downsideOvervalued by 40.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4.67 Million |
|---|---|
| Enterprise Value | $2.33 Million |
| Earnings per Share | $-33.06 |
| Beta | 1.07 |
| Outstanding Shares | 694,000 |
Return
| Return on Equity | -75.24% |
|---|---|
| Return on Assets | -68.63% |
| Return on Invested Capital | -78.97% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.73 |
| Price to Sales | - |
| Price to Book Ratio | 0.23 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.14 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 30, 2026
EPS Estimate
$-3.27
Consensus analyst estimateRevenue Estimate
$2.25 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-3.27
Consensus analyst estimateRevenue Estimate
$2.25 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.08%▼ 13.14% |
|---|---|
| Total Invested | $4,212▼ 99.56% |
| Investors Holding | 2▼ 15.00% |
About enVVeno Medical Corporation
19 employees
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product c...